Home / Leaderboard / Martin Currie Ltd.
Martin Currie Ltd.
Jen Mair · Asset Manager · Growth
Martin Currie Ltd is an active equity specialist investment management firm headquartered in Edinburgh, Scotland. Founded in 1881, the firm has a long history, initially funding the expansion of railroads across the United States. Today, it operates as a specialist investment manager within the Franklin Templeton group, offering a range of high-conviction global, emerging market, and regional equity solutions. The firm is well-regarded for its rigorous fundamental research and its commitment to industry-leading ESG integration. While Franklin Templeton announced plans in 2025 to align the Martin Currie brand under its ClearBridge and Franklin Equity entities, the investment teams continue to operate with their established autonomy, focusing on delivering long-term capital growth and income for institutional and retail clients worldwide.
Simulated Performance
| Metric | Value |
|---|---|
| Total return | +8.2% |
| YTD return | +5.4% |
| Sharpe ratio | 3.50 |
| Win rate | 53% |
| AUM | $1.8B |
| Inception | Oct 1, 2025 |
| Updated | Sep 4, 2026 |
Institution Status
| Field | Value |
|---|---|
| AUM | $1.8B |
| Turnover | Low (<15%) |
| Avg holding | 18 Months |
| Inception | Oct 1, 2025 |
| Website | https://www.martincurrie.com |
Current Holdings
Updated on Sep 4, 2026.
| Ticker | Name | Portfolio % | Return |
|---|---|---|---|
| AZN | AstraZeneca PLC | 9.9% | -12.0% |
| BP | BP PLC ADR | 8.3% | +8.8% |
| SHEL | Shell PLC ADR | 8.1% | +14.3% |
| GSK | GlaxoSmithKline PLC ADR | 7.4% | -0.3% |
| HSBC | HSBC Holdings PLC ADR | 6.4% | +35.1% |
| RIO | Rio Tinto ADR | 6.1% | +21.7% |
| BTI | British American Tobacco p.l.c. | 5.5% | -1.2% |
| NWG | Natwest Group PLC | 5.4% | +23.7% |
| BCS | Barclays PLC ADR | 5.3% | +20.7% |
| BAESY | BAE Systems PLC | 5.2% | +0.0% |
| UL | Unilever PLC ADR | 5.2% | +3.1% |
| NGG | National Grid PLC ADR | 5.0% | -9.6% |
| RELX | Relx PLC ADR | 3.2% | +6.3% |
| IMBBY | Imperial Brands PLC | 3.2% | 0.0% |
| SSEZY | SSE PLC ADR | 3.0% | 0.0% |
| TSCDY | Tesco PLC | 3.0% | 0.0% |
| SNN | Smith & Nephew SNATS Inc | 2.7% | -8.6% |
| NVDA | NVIDIA Corporation | 2.6% | +19.8% |
| MSFT | Microsoft Corporation | 2.3% | +6.1% |
| LGGNY | Legal & General Group Plc | 2.3% | +0.0% |
Recent activity
| Date | Action | Ticker | Weight |
|---|---|---|---|
| Aug 31, 2026 | SELL | TSCDY | 3.0% → 3.0% |
| Aug 31, 2026 | SELL | RELX | 3.2% → 3.2% |
| Aug 31, 2026 | BUY | NWG | 5.4% → 5.4% |
| Aug 31, 2026 | SELL | SSEZY | 3.0% → 3.0% |
| Aug 31, 2026 | BUY | RIO | 6.1% → 6.1% |
Investment Style Analysis
Martin Currie Ltd. is widely recognized for employing a Growth strategy. As of Sep 4, 2026, the firm oversees approximately $1.8B in assets under management (AUM). The portfolio demonstrates a clear preference for the Drug Manufacturers - General and Oil & Gas Integrated sectors, reflecting a high-conviction approach to capital allocation.
Recent Market Moves
During the latest rebalancing period ending Aug 31, Martin Currie Ltd. made a significant move by reducing the position in TSCDY. This adjustment aligns with the fund's dynamic approach to risk management and capital deployment in current market conditions.
Investment Philosophy
Martin Currie’s investment philosophy is based on the belief that active, high-conviction stock picking driven by fundamental research is the most effective way to identify high-quality companies undervalued by the market. The firm focuses on 'quality growth'—investing in businesses with sustainable business models, strong balance sheets, and the potential for long-term value creation. Central to their strategy is the deep integration of environmental, social, and governance (ESG) factors, which they view as fundamentally intertwined with financial performance. By embedding ESG analysis and active stewardship into their process, the firm aims to gain a holistic understanding of material risks and opportunities, ultimately seeking to deliver superior risk-adjusted returns through concentrated portfolios of their best ideas.
Disclaimer
The content provided on this page, including the simulated portfolio performance, holdings analysis, and AI-generated insights, is for informational and educational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. All data is derived from historical SEC 13F filings and other public disclosures, which have a reporting lag. The "Simulated Performance" is a hypothetical reconstruction based on past disclosures and does not represent the actual returns of the institution. Past performance is not indicative of future results. Tritonix.ai is not affiliated with Martin Currie Ltd..
Similar Investment Style
Based on Growth.
- Jaunty Global Limited — Alvin Jiang · 3M +32.6%
- Summit Partners, L.P. — Peter Y. Chung · 3M +39.0%
- Oberweis Asset Management, Inc. — James W. Oberweis · 3M -16.2%
- Hartline Investment Corporation — Brian W. Hart · 3M +2.8%
Frequently asked questions
How is the simulated portfolio for Martin Currie Ltd. constructed?
This simulation is powered by Tritonix AI using official SEC filings. We focus on the "Best Ideas" by filtering for only the Top 20 largest holdings and rebalancing them to 100%. The simulation tracks performance starting from Oct 1, 2025. Our AI monitors for updates every Monday to capture major shifts. This concentrated approach highlights the manager's true stock-picking skill and mirrors their actual investment returns.
What is Martin Currie Ltd.'s largest holding?
As of the latest filing, Martin Currie Ltd.'s top position is AstraZeneca PLC (AZN), representing 9.9% of the portfolio. This reflects a high-conviction bet by the institution.
What is Martin Currie Ltd.'s historical performance and risk profile?
Our simulation indicates a total return of +8.2% with a win rate of 53%. Notably, the portfolio maintains a Sharpe Ratio of 3.50, suggesting an exceptional level of risk-adjusted returns compared to the broader market.
What sectors does Martin Currie Ltd. primarily invest in?
Martin Currie Ltd. has a strong preference for the Drug Manufacturers - General sector, which makes up 17.3% of their disclosed assets. The portfolio also has exposure to Oil & Gas Integrated, indicating a specific thematic focus.
Is Martin Currie Ltd.'s portfolio concentrated or diversified?
Martin Currie Ltd. runs a moderately concentrated portfolio with 20 disclosed positions. The top 3 holdings alone account for 26.3% of the total portfolio weight, suggesting a strategy that favors broader market exposure.
How has Martin Currie Ltd. performed in 2026?
Our AI-simulated model portfolio for Martin Currie Ltd. tracks a Year-to-Date (YTD) return of +5.4%. This metric helps investors gauge the institution's effectiveness in the current market environment.
Does Jen Mair manage Martin Currie Ltd. directly?
Yes, Jen Mair serves as the key portfolio manager for Martin Currie Ltd., overseeing the investment strategy and final capital allocation decisions.